Kim Blickenstaff Insider Profile

11 Followers
Kim Blickenstaff, Director at Tandem Diabetes Care, holds 172.19K shares in Nuvation Bio (Ticker: NUVB), holds 223.04K shares in Tandem Diabetes Care (Ticker: TNDM), holds 7.38K shares in Medivation (Ticker: MDVN). Most recently, Kim Blickenstaff Bought ― shares of Nuvation Bio on Jun 13, 2024 for an estimated value of 499.35K.
tipranks
Kim Blickenstaff

Kim Blickenstaff
Tandem Diabetes Care (TNDM)
Director

Ranked #259 out of 99,218 Corporate Insiders

Profitable Transactions

39%
9 out of 23 Profitable Transactions

Average Return

+62.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
89.71%
6.52%
3.77%
A breakdown of Kim Blickenstaff's holdings

Insider Roles

Tandem Diabetes Care
(TNDM)
Director
Nuvation Bio
(NUVB)
Director
Dexcom
(DXCM)
Director
Roles that Kim Blickenstaff holds in companies

Most Profitable Insider Trade

Stock:
Tandem Diabetes Care
(TNDM)
Rating:Informative Buy
Date:Oct 17, 2017 - Oct 17, 2018
Return:+800.00%
The most profitable trade made by Kim Blickenstaff

Kim Blickenstaff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tandem Diabetes Care
May 24, 2024
Director
Uninformative Buy
229.37K
$6.82M
Nuvation Bio
Jun 13, 2024
Director
Informative Buy
499.35K
$495.90K
MDVN
Medivation
Sep 30, 2016
Uninformative Sell
$596.78K
Dexcom
Director
$287.12K
List of latest transactions for each holding click on a transaction to see Kim Blickenstaff's performance on stock

Kim Blickenstaff insider profile FAQ

What is the percentage of profitable transactions made by Kim Blickenstaff?
The percentage of profitable transactions made by Kim Blickenstaff is 39%.
    What is the average return per transaction made by Kim Blickenstaff?
    The average return per transaction made by Kim Blickenstaff is 62.10%.
      What stocks does Kim Blickenstaff hold?
      Kim Blickenstaff holds: TNDM, NUVB, MDVN, DXCM stocks.
        What was Kim Blickenstaff’s latest transaction?
        Kim Blickenstaff latest transaction was an Informative Buy of $499.35K.
          What was Kim Blickenstaff's most profitable transaction?
          Kim Blickenstaff’s most profitable transaction was an Informative Buy of TNDM stock on October 17, 2017. The return on the trade was 800.00%.
            What is Kim Blickenstaff's role in Tandem Diabetes Care?
            Kim Blickenstaff's role in Tandem Diabetes Care is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.